Belgian Left Atrial Appendage Occlusion Meeting
3rd Belgian Left Atrial Appendage Occlusion Meeting
 


Thursday 23 November 2018 - Hotel DOLCE, La Hulpe
12:30 - 18:00


Dear Colleagues,

Oral anticoagulation remains the mainstay of therapy for stroke prevention in patients with atrial fibrillation. However, a significant proportion of patients at risk of stroke can not tolerate these drugs because of significant side effects, including bleeding complications. Percutaneous Left atrial appendage occlusion (LAAO) is increasingly recognized as a valid alternative to oral anticoagulation in patients at risk of stroke and with previous major bleeding events or at high bleeding risk.

LAAO is still at an early phase in many centers in Belgium and we need to provide a concise overview of the current evidence together with key message about optimal imaging and implantation, prevention and management of complications

This half-day course is designed to give you an overview on all aspects of this treatment modality and how to select patients optimally.

We look forward to seeing you in La Hulpe,

On behalf of the scientific committee

Adel Aminian, MD